Pharmaplasia (TM)
In Pharmaplasia, Mike Wokasch a 30 – year industry veteran, explores the root causes of the industry’s current state of dysfunction and offers practical solutions for change, even in light of the increasing regulatory constraints, restrictions on marketing and sales, and the increasing demands of a cost conscious market driven by healthcare reform.
The author provides an insider’s view of the unintended consequences of the industry’s rapid growth over the past several decades and explains why some Big Pharma companies may indeed be too large to be managed efficiently and effectively. Much like the author’s blog, Pharma Reform, the book presents a hard hitting discussion of how the industry’s mistakes and poor decisions led to diminished public trust and credibility while raising serious questions about the long-term viability of its outdated business model.
The book addresses additional important questions:
- Why hasn’t increased R & D spending led to more innovative products?
- How can pharmaceutical companies reestablish trust and credibility?
- How can sales representatives survive the current industry turmoil?
- Why do prescription drugs cost so much?
- How should the industry respond to the increasing complexity of the market?
- How should the pharmaceutical industry adapt to Healthcare Reform?
… Pharmaplasia is important reading for anyone with a vested interest in the pharmaceutical industry (especially those who work in it).”
ForeWord CLARION Reviews
“Wokasch’s insightful view of the pharmaceutical industry offers some logical explanations for the volatile changes and disappointment in that once proud business sector. As a senior level insider with access to key decision makers, Mike is able to provide both concrete examples and an educated perspective of the pinnacles and pitfalls surrounding this important segment of our economy and lives. This is a must read for both senior level pharma executives and those aspiring to bring back the real value to this once respected industry.” Jim Patchen (former pharma colleague of Mike Wokasch)
“(book) Came today and I read it straight thru. YES! I can certainly relate to the things you said in there! I just kept saying, how true, how true! ” C. Karabin (former pharma colleague of Mike Wokasch)
Who should read this book?
- Pharmaceutical industry executives and employees will learn how to manage and lead in this evolving new healthcare market, increase R & D productivity, preserve profitability, and reestablish public trust and credibility.
- Pharmaceutical industry providers and suppliers will learn about the critical challenges the industry faces.
- Legislators and regulators will appreciate the need for a strong regulatory environment that is backed up by fair and consistent enforcement practices.
- Patients and the general public will learn about the inner workings of pharmaceutical companies as the author debunks myths and demystifies popular misunderstandings.
- Executives in other industries will learn valuable case study management and leadership lessons including how to avoid the unintended consequences that often accompany rapid, uncontrolled growth.
Special Pricing!
Special Pricing is available for orders placed in conjunction with paid speaking engagements. E-mail mike@pharmareform.com for special pricing or go to invite Mike to speak.